KR30031, CAS [[205535-74-6]]

Artikelnummer: TGM-T69956
Artikelname: KR30031, CAS [[205535-74-6]]
Artikelnummer: TGM-T69956
Hersteller Artikelnummer: T69956
Alternativnummer: TGM-T69956-25MG,TGM-T69956-50MG,TGM-T69956-100MG
Hersteller: TargetMol
Kategorie: Biochemikalien
KR30031 is a novel P-glycoprotein inhibitor with potential anticancer activity. KR30031 is a verapamil analog with fewer cardiovascular effects. The ability of KR-30031 to reduce this efflux transport is equal to that of verapamil, a well-known P-glycoprotein inhibitor. The bioavailability of paclitaxel could be enhanced by coadministration of a P-glycoprotein inhibitor, KR-30031.
Molekulargewicht: 438.56
CAS Nummer: [205535-74-6]
Formel: C26H34N2O4
Target-Kategorie: P-gp|||Others
T69956